Works matching AU PERKOVIC, VLADO

Results: 183
    1

    Canagliflozin and iron metabolism in the CREDENCE trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 4, p. 696, doi. 10.1093/ndt/gfae198
    By:
    • Koshino, Akihiko;
    • Heerspink, Hiddo J L;
    • Jongs, Niels;
    • Badve, Sunil V;
    • Arnott, Clare;
    • Neal, Bruce;
    • Jardine, Meg;
    • Mahaffey, Kenneth W;
    • Pollock, Carol;
    • Perkovic, Vlado;
    • Hansen, Michael K;
    • Bakker, Stephan J L;
    • Wada, Takashi;
    • Neuen, Brendon L
    Publication type:
    Article
    2
    3

    The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.

    Published in:
    Redox Report, 2016, v. 21, n. 1, p. 14, doi. 10.1179/1351000215Y.0000000022
    By:
    • Zhang, Lei;
    • Coombes, Jeff;
    • Pascoe, Elaine M.;
    • Badve, Sunil V.;
    • Dalziel, Kim;
    • Cass, Alan;
    • Clarke, Philip;
    • Ferrari, Paolo;
    • McDonald, Stephen P.;
    • Morrish, Alicia T.;
    • Pedagogos, Eugenie;
    • Perkovic, Vlado;
    • Reidlinger, Donna;
    • Scaria, Anish;
    • Walker, Rowan;
    • Vergara, Liza A.;
    • Hawley, Carmel M.;
    • Johnson, David W.;
    • on behalf of the HERO Study Collaborative Group
    Publication type:
    Article
    4
    5

    Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772
    By:
    • Li, Chao;
    • Yu, Jie;
    • Hockham, Carinna;
    • Perkovic, Vlado;
    • Neuen, Brendon L.;
    • Badve, Sunil V.;
    • Houston, Lauren;
    • Lee, Vivian Y. J.;
    • Barraclough, Jennifer Y.;
    • Fletcher, Robert A.;
    • Mahaffey, Kenneth W.;
    • Heerspink, Hiddo J. L.;
    • Cannon, Christopher P.;
    • Neal, Bruce;
    • Arnott, Clare
    Publication type:
    Article
    6
    7
    8
    9
    10

    The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
    By:
    • Arnott, Clare;
    • Li, Jing‐Wei;
    • Cannon, Christopher P.;
    • Zeeuw, Dick;
    • Neuen, Brendon L.;
    • Heerspink, Hiddo J. L.;
    • Charytan, David M.;
    • Agarwal, Anubha;
    • Huffman, Mark D.;
    • Figtree, Gemma A.;
    • Bakris, George;
    • Chang, Tara I‐Hsin;
    • Feng, Kent;
    • Rosenthal, Norman;
    • Zinman, Bernard;
    • Jardine, Meg J.;
    • Perkovic, Vlado;
    • Neal, Bruce;
    • Mahaffey, Kenneth W.
    Publication type:
    Article
    11
    12
    13

    Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 561, doi. 10.1111/dom.14252
    By:
    • Koomen, Jeroen V.;
    • Stevens, Jasper;
    • Bakris, George;
    • Correa‐Rotter, Ricardo;
    • Hou, Fan Fan;
    • Kitzman, Dalane W.;
    • Kohan, Donald;
    • Makino, Hirofumi;
    • McMurray, John J. V.;
    • Parving, Hans‐Henrik;
    • Perkovic, Vlado;
    • Tobe, Sheldon W.;
    • Zeeuw, Dick;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    Baseline characteristics and enrichment results from the SONAR trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1829, doi. 10.1111/dom.13315
    By:
    • Heerspink, Hiddo J. L.;
    • Andress, Dennis L.;
    • Bakris, George;
    • Brennan, John J.;
    • Correa‐Rotter, Ricardo;
    • Hou, Fan Fan;
    • Kitzman, Dalane W.;
    • Kohan, Donald;
    • Makino, Hirofumi;
    • McMurray, John;
    • Perkovic, Vlado;
    • Tobe, Sheldon;
    • Wigderson, Melissa;
    • Yi, Tingting;
    • Parving, Hans‐Henrik;
    • de Zeeuw, Dick
    Publication type:
    Article
    22

    Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1369, doi. 10.1111/dom.13245
    By:
    • Heerspink, Hiddo J. L.;
    • de Zeeuw, Dick;
    • Perkovic, Vlado;
    • Tobe, Sheldon;
    • Parving, Hans‐Henrik;
    • Andress, Dennis L.;
    • Brennan, John J.;
    • Dey, Jyotirmoy;
    • Wigderson, Melissa;
    • Bakris, George;
    • Correa‐Rotter, Ricardo;
    • Hou, Fan Fan;
    • Kitzman, Dalane W.;
    • Kohan, Donald;
    • Makino, Hirofumi;
    • McMurray, John
    Publication type:
    Article
    23

    Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA- T2D trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1610, doi. 10.1111/dom.13041
    By:
    • Groop, Per‐Henrik;
    • Cooper, Mark E.;
    • Perkovic, Vlado;
    • Hocher, Berthold;
    • Kanasaki, Keizo;
    • Haneda, Masakazu;
    • Schernthaner, Guntram;
    • Sharma, Kumar;
    • Stanton, Robert C.;
    • Toto, Robert;
    • Cescutti, Jessica;
    • Gordat, Maud;
    • Meinicke, Thomas;
    • Koitka‐Weber, Audrey;
    • Thiemann, Sandra;
    • von Eynatten, Maximilian
    Publication type:
    Article
    24
    25

    The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 749, doi. 10.1111/dom.12864
    By:
    • Pena, Michelle J.;
    • de Zeeuw, Dick;
    • Andress, Dennis;
    • Brennan, John J.;
    • Correa‐Rotter, Ricardo;
    • Coll, Blai;
    • Kohan, Donald E.;
    • Makino, Hirofumi;
    • Perkovic, Vlado;
    • Remuzzi, Giuseppe;
    • Tobe, Sheldon W.;
    • Toto, Robert;
    • Parving, Hans‐Henrik;
    • Sharma, Shoba;
    • Corringham, Tom;
    • Sharma, Kumar;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    26
    27
    28
    29

    Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA–T2D<sup>™</sup> trial.

    Published in:
    Diabetes & Vascular Disease Research, 2015, v. 12, n. 6, p. 455, doi. 10.1177/1479164115579002
    By:
    • Groop, Per-Henrik;
    • Cooper, Mark E.;
    • Perkovic, Vlado;
    • Sharma, Kumar;
    • Schernthaner, Guntram;
    • Haneda, Masakazu;
    • Hocher, Berthold;
    • Gordat, Maud;
    • Cescutti, Jessica;
    • Woerle, Hans-Juergen;
    • von Eynatten, Maximilian
    Publication type:
    Article
    30
    31
    32

    The Authors Reply:.

    Published in:
    Kidney International, 2013, v. 84, n. 3, p. 622, doi. 10.1038/ki.2013.241
    By:
    • Perkovic, Vlado;
    • Woodward, Mark;
    • Zoungas, Sophia;
    • Chalmers, John
    Publication type:
    Article
    33

    Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.

    Published in:
    Kidney International, 2013, v. 83, n. 3, p. 517, doi. 10.1038/ki.2012.401
    By:
    • Perkovic, Vlado;
    • Heerspink, Hiddo Lambers;
    • Chalmers, John;
    • Woodward, Mark;
    • Jun, Min;
    • Li, Qiang;
    • MacMahon, Stephen;
    • Cooper, Mark E;
    • Hamet, Pavel;
    • Marre, Michel;
    • Mogensen, Carl Erik;
    • Poulter, Neil;
    • Mancia, Giuseppe;
    • Cass, Alan;
    • Patel, Anushka;
    • Zoungas, Sophia
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50